Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Evaluation of the Fibrin Assay for Venous Thromboembolism Exclusion in Cancer Patients: Subanalysis of a Prospective Assessment (FSET STUDY)

Isabelle Mahe, MD PhD, Jean Chidiac, MD, Sadji Djennaoui, MD, Nicolas Javaud, MD PhD, Benjamin Planquette, MD PhD, Edith Peynaud-Debayle, MD, Laurent Sofiane Baccar, MD, Bénédicte Dumont, PhD, Guy Meyer, Geneviève Contant, PhD, Francois Depasse, PharmD, Virginie Siguret, PhD, Hélène Helfer, PhD

Blood (2019) 134 (Supplement_1): 3663.

https://doi.org/10.1182/blood-2019-124973

Published: 2019

Journal Articles

Real-World Rates and Management of Thrombocytopenia Due to Cancer Treatment in Advanced/Metastatic Female Genitourinary Malignancies

Joshua F Ransom, PhD, Aaron Galaznik, MDMBA, Emelly Rusli, Bruno Lempernesse, MS, Marc Berger, MD

Blood (2019) 134 (Supplement_1): 4895.

https://doi.org/10.1182/blood-2019-129086

Published: 2019

Journal Articles

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Deborah Y. Park, BS, Shyam K. Poudel, MD, Xuefei Jia, MS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS,AOCN, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Dana E. Angelini, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1237.

https://doi.org/10.1182/blood-2018-99-111897

Published: 2018

Journal Articles

Does Mixed Chimerism after Allogeneic Hematopoietic Cell Transplantation in Patients with Fanconi Anemia Impact on Outcome?

Mouhab Ayas, MD, Khawar Siddiqui, Antonette Amao, Abdullah Aljefri, MD, Ali Abdallah Ahmari, MD, Ibrahim A. Ghemlas, MBBS, Hawazen S. Alsaedi, MD, Awatif Alanazi, MD, Amal Al-Seraihy, MD

Blood (2018) 132 (Supplement 1): 4588.

https://doi.org/10.1182/blood-2018-99-112330

Published: 2018

Journal Articles

What Predicts Venous Thromboembolism Among Cancer Inpatients: A Proposed Predictive Model

Shiva Shrotriya, MBBS, Prajwal Dhakal, MBBS, Mukta Sharma, MBBS, Joseph Gardiner, Alexa Lupi, MS, Supratik Rayamajhi, MD

Blood (2017) 130 (Supplement 1): 3708.

https://doi.org/10.1182/blood.V130.Suppl_1.3708.3708

Published: 2017

Journal Articles

Posttransplant Secondary Neoplasms: A Single Center Experience

Selin Berk, MD, Dilek Keskin, MD, Nurgul Ozgur Yurttas, MD, Sevil Sadri, MD, Isil Erdogan, MD, Firat Yalniz, MD, Tugrul Elverdi, MD, Ayse Salihoglu, MD, Ahmet Emre Eskazan, MD, M. Cem Ar, MD PhD, Seniz Ongoren, MD Associated Proffessor, Zafer Baslar, MD, Nukhet Tuzuner, MD Professor, Yildiz Aydin, MD, Teoman Soysal, MD

Blood (2015) 126 (23): 5485.

https://doi.org/10.1182/blood.V126.23.5485.5485

Published: 2015

Journal Articles

Incidence of Treatment-Related, Laboratory and Clinical Tumor Lysis Syndrome

Mitchell S. Cairo, MD, Stephen Thompson, Lee Stern, Steven Sherman, MS

Blood (2012) 120 (21): 238.

https://doi.org/10.1182/blood.V120.21.238.238

Published: 2012

Journal Articles

Incidence, Treatment, and Consequences of Chemotherapy-Induced Febrile Neutropenia in Inpatient and Outpatient Settings

Derek Weycker, Ph.D., Richard Barron, MS, Alex Kartashov, Ph.D., Jason C. Legg, Gary H. Lyman, MD, MPH

Blood (2012) 120 (21): 4232.

https://doi.org/10.1182/blood.V120.21.4232.4232

Published: 2012

Journal Articles

Clinical Outcomes After Inferior Vena Cava Filter (IVCF) Placement in Cancer Patients: A Retrospective Study.

Anand Narayan, BA, Hyun Kim, MD, Kelvin Hong, Adrea Lee, MD, Michael B. Streiff, MD

Blood (2009) 114 (22): 1076.

https://doi.org/10.1182/blood.V114.22.1076.1076

Published: 2009

Journal Articles

Tissue Factor and Cancer Procoagulant as Predictors of Thrombosis or Progression in Cancer Patients.

Soledad Molnar, MD, Hugo Guglielmone, MCs, Salvador Minoldo, MD, Maria L. Rizzi, MD, Marcelo Lavarda, MD, Gustavo Jarchum, MD

Blood (2007) 110 (11): 3136.

https://doi.org/10.1182/blood.V110.11.3136.3136

Published: 2007

Journal Articles

Tumor Site and Metastases as Predictors of Venous Thromboembolism Recurrence among Active Cancer Patients with Incident Deep Vein Thrombosis or Pulmonary Embolism: A Population-Based Cohort Study.

Cheng E. Chee, MD, John A. Heit, MD, Aneel A. Ashrani, MD, Tanya M. Petterson, MS, Sara A. Farmer, Kent R. Bailey, PhD, L. Joseph Melton, III, MD,MPH

Blood (2006) 108 (11): 4096.

https://doi.org/10.1182/blood.V108.11.4096.4096

Published: 2006

NARROW

Evaluation of the Fibrin Assay for Venous Thromboembolism Exclusion in Cancer Patients: Subanalysis of a Prospective Assessment (FSET STUDY)

Real-World Rates and Management of Thrombocytopenia Due to Cancer Treatment in Advanced/Metastatic Female Genitourinary Malignancies

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Does Mixed Chimerism after Allogeneic Hematopoietic Cell Transplantation in Patients with Fanconi Anemia Impact on Outcome?

What Predicts Venous Thromboembolism Among Cancer Inpatients: A Proposed Predictive Model

Posttransplant Secondary Neoplasms: A Single Center Experience

Incidence of Treatment-Related, Laboratory and Clinical Tumor Lysis Syndrome

Incidence, Treatment, and Consequences of Chemotherapy-Induced Febrile Neutropenia in Inpatient and Outpatient Settings

Clinical Outcomes After Inferior Vena Cava Filter (IVCF) Placement in Cancer Patients: A Retrospective Study.

Tissue Factor and Cancer Procoagulant as Predictors of Thrombosis or Progression in Cancer Patients.

Tumor Site and Metastases as Predictors of Venous Thromboembolism Recurrence among Active Cancer Patients with Incident Deep Vein Thrombosis or Pulmonary Embolism: A Population-Based Cohort Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only